William D. Figg

Also affiliated with National Cancer Institute, Center for Cancer Research, National Institutes of Health Clinical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned

British Journal of Haematology(2025)10.1111/bjh.20069

Top 78%

0.104DataRank

Top 78%1 citations

Noa G. Holtzman, Rania Hishmeh, Alain Mina, Eduard Schulz, Anita Stokes +9 more

Papers

Driven by 32 papers — median percentile 22. Top paper: “Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab”.

Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab

Gut(2025)10.1136/gutjnl-2024-334026

N/A

0.567DataRank · unranked

18 citations

Sepideh Babaei, Rajiv Trehan, Christoph Hoffman, Noémi Kedei, Benjamin Ruf +33 more

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers

Frontiers in Oncology(2024)10.3389/fonc.2024.1386190

N/A

0.421DataRank · unranked

9 citations

Cody J. Peer, Xianyu Zhang, Hyoyoung Choo‐Wosoba, Mehwish Ahmad, Min-Jung Lee +13 more

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial

Pediatric Blood & Cancer(2025)10.1002/pbc.31584

N/A

0.165DataRank · unranked

2 citations

Eric S. Schafer, Yueh‐Yun Chi, Jemily Malvar, Kenneth Heym, Andrew E. Place +22 more

Phase 1 Study of Oral N-Acetylmannosamine in Primary Podocytopathies

Kidney International Reports(2025)10.1016/j.ekir.2025.103758

N/A

0.104DataRank · unranked

1 citations

Anirban Ganguli, Jonathan Bolaños, Petcharat Leoyklang, Kenneth J. Wilkins, Yi Arial Zeng +10 more

A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned

British Journal of Haematology(2025)10.1111/bjh.20069

Top 78%

0.104DataRank

Top 78%1 citations

Noa G. Holtzman, Rania Hishmeh, Alain Mina, Eduard Schulz, Anita Stokes +9 more

Drug-drug Interactions in Patients with HIV and Cancer in Sub-Saharan Africa

Aids Reviews(2021)10.24875/aidsrev.20000005

N/A

0DataRank · unranked

9 citations

Elad Sharon, Jonathan D. Strope, Prabha Chandrasekaran, Ravie Kem, Robert Yarchoan +5 more

The Dietary Supplement Health And Education Act: are we healthier and better informed after 27 years?

The Lancet Oncology(2021)10.1016/s1470-2045(21)00084-x

N/A

0DataRank · unranked

7 citations

Lisa M. Cordes, William D. Figg, Tristan M. Sissung

Subcutaneous Atezolizumab: A Jab Without a Benefit

Clinical Pharmacology in Drug Development(2021)10.1002/cpdd.1061

N/A

0DataRank · unranked

4 citations

Sara Zimmerman, William D. Figg, Daniel A. Goldstein, Mark J. Ratain, Cody J. Peer

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers

Scientific Reports(2021)10.1038/s41598-021-84960-w

N/A

0DataRank · unranked

3 citations

Barış Türkbey, Billel Gasmi, Keith T. Schmidt, Jonathan D. Strope, Cindy H. Chau +15 more

Functional Drug Screening in the Era of Precision Medicine

Frontiers in Medicine(2022)10.3389/fmed.2022.912641

N/A

0DataRank · unranked

33 citations

William D. Figg, Cindy H. Chau, Giulia C. Napoli

Lutetium-177-PSMA-617: A Vision of the Future

Cancer Biology & Therapy(2022)10.1080/15384047.2022.2037985

N/A

0DataRank · unranked

27 citations

William D. Figg, Ravi A. Madan, Elias Chandran

Single whole genome sequencing analysis blazes the trail for precision medicine

Cancer Biology & Therapy(2022)10.1080/15384047.2022.2033058

N/A

0DataRank · unranked

2 citations

Cindy H. Chau, William D. Figg, Giulia C. Napoli

Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)

Neuro-Oncology(2023)10.1093/neuonc/noad141

N/A

0DataRank · unranked

64 citations

Tabitha Cooney, John Glod, Jie Huang, Cody J. Peer, Damien Faury +14 more

GNRH2Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy

Anticancer Research(2023)10.21873/anticanres.16590

N/A

0DataRank · unranked

2 citations

Sarah E. Lochrin, TYLER LIU, Keith T. Schmidt, Jonathan D. Strope, Emily N. Risdon +8 more

Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3

Journal of Cancer(2023)10.7150/jca.90836

N/A

0DataRank · unranked

2 citations

Erica L. Beatson, Martina A. Knechel, Elijah Richard Sommer, Giulia C. Napoli, Emily N. Risdon +7 more

SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11519

N/A

0DataRank · unranked

14 citations

Karla V. Ballman, Rachel S. Heise, John Glod, Mary Frances Wedekind, Leo Mascarenhas +15 more

Data from Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

(2023)10.1158/1055-9965.c.6515155

N/A

0DataRank · unranked

0 citations

Cathee Till, Phyllis J. Goodman, Howard L. Parnes, William D. Figg, Demetrius Albanes +5 more

Data from Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

(2023)10.1158/1055-9965.c.6515155.v1

N/A

0DataRank · unranked

0 citations

Cathee Till, Phyllis J. Goodman, Howard L. Parnes, William D. Figg, Demetrius Albanes +5 more

Data from Impact of ABCB1 Allelic Variants on QTc Interval Prolongation

(2023)10.1158/1078-0432.c.6518514

N/A

0DataRank · unranked

0 citations

Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo +14 more

Data from Impact of ABCB1 Allelic Variants on QTc Interval Prolongation

(2023)10.1158/1078-0432.c.6518514.v1

N/A

0DataRank · unranked

0 citations

Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo +14 more

Data from A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

(2023)10.1158/1078-0432.c.6519969.v1

N/A

0DataRank · unranked

0 citations

Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz +8 more

Data from The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

(2023)10.1158/1535-7163.c.6532077.v1

N/A

0DataRank · unranked

0 citations

Craig Vargo, Romano Danesi, Tristan M. Sissung, Douglas K. Price, David Venzon +3 more

Data from Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy

(2023)10.1158/1078-0432.c.6518572

N/A

0DataRank · unranked

0 citations

John W. Gillespie, Yajun Yi, Gadisetti V.R. Chandramouli, Mark A. Perlmutter, Yvonne Gathright +13 more

New Discorhabdin D Analogues from Latrunculia spp. Sponges

Journal of Natural Products(2024)10.1021/acs.jnatprod.4c01036

N/A

0DataRank · unranked

2 citations

Masoumeh Dalilian, Lin Du, Cindy H. Chau, William D. Figg, Barry R. O’Keefe +2 more

SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11508

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Rachel S. Heise, Leo Mascarenhas, John Glod, Mary Frances Frances Wedekind +14 more

Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study

Research Square(2024)10.21203/rs.3.rs-4656461/v1

N/A

0DataRank · unranked

0 citations

Ilana Schlam, Dylan M. Smith, Cody Peer, Tristan M. Sissung, Keith T. Schmidt +16 more

On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs

Biochemical and Biophysical Research Communications(2020)10.1016/j.bbrc.2020.11.117

N/A

0DataRank · unranked

18 citations

Samuel Maiwald, Christian Steinebach, Matthew K. Collins, Jonathan D. Strope, Cindy H. Chau +4 more

Determination of the pyrrolo[2,3-d] pyrimidine antifolate AGF94 from a preclinical murine study using a simple UHPLC-MS/MS assay

Journal of Chromatography B(2025)10.1016/j.jchromb.2025.124833

N/A

0DataRank · unranked

0 citations

Robynne Ashe, Alexander Duncan, Ethan C. Wilner, Keith T. Schmidt, Kristbjorn O. Gudmundsson +6 more

A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03627-0

N/A

0DataRank · unranked

10 citations

Stewart Goldman, Aradhana Kaushal, Andra Krauze, Deborah E. Citrin, John Glod +17 more

Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa005

N/A

0DataRank · unranked

9 citations

Louis Rodgers, Rafael Pereira da Cruz, Marvin L. Thomas, Cody J. Peer, William D. Figg +2 more

A phase II trial of the DNA methyl transferase inhibitor, SGI-110 (Guadecitabine), in children and adults with SDH-deficient GIST, pheochromocytoma, and paraganglioma, and HLRCC-associated kidney cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11540

N/A

0DataRank · unranked

5 citations

Jaydira Del Rivero, Fernanda I. Arnaldez, Ramaprasad Srinivasan, Melissa Spencer, Seth M. Steinberg +8 more

Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p

Scientific Reports(2021)10.1038/s41598-021-90143-4

N/A

0DataRank · unranked

23 citations

Edel M. McCrea, Kristi Y. Lee, Jonathan D. Strope, Emily N. Risdon, Douglas K. Price +3 more

William D. Figg

Indexed papers

Top data-sharing exemplar

Papers